Jane Street Group LLC grew its stake in Cabot Co. (NYSE:CBT - Free Report) by 86.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 100,073 shares of the specialty chemicals company's stock after purchasing an additional 46,444 shares during the quarter. Jane Street Group LLC owned approximately 0.18% of Cabot worth $9,138,000 as of its most recent SEC filing.
Other hedge funds also recently modified their holdings of the company. GAMMA Investing LLC boosted its stake in Cabot by 10.7% in the fourth quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company's stock valued at $123,000 after acquiring an additional 130 shares during the last quarter. Personal CFO Solutions LLC raised its holdings in shares of Cabot by 3.3% in the 4th quarter. Personal CFO Solutions LLC now owns 4,285 shares of the specialty chemicals company's stock worth $391,000 after purchasing an additional 137 shares during the period. Isthmus Partners LLC lifted its stake in Cabot by 4.8% in the fourth quarter. Isthmus Partners LLC now owns 4,072 shares of the specialty chemicals company's stock valued at $372,000 after purchasing an additional 187 shares during the last quarter. Neuberger Berman Group LLC grew its holdings in Cabot by 1.2% during the fourth quarter. Neuberger Berman Group LLC now owns 18,238 shares of the specialty chemicals company's stock valued at $1,665,000 after purchasing an additional 212 shares during the period. Finally, EverSource Wealth Advisors LLC increased its position in Cabot by 37.2% in the fourth quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company's stock worth $74,000 after buying an additional 219 shares during the last quarter. Institutional investors and hedge funds own 93.18% of the company's stock.
Cabot Stock Performance
Shares of Cabot stock traded up $0.87 during trading hours on Tuesday, reaching $76.98. The company had a trading volume of 81,291 shares, compared to its average volume of 402,210. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.00 and a quick ratio of 1.29. Cabot Co. has a one year low of $71.64 and a one year high of $117.46. The firm has a market cap of $4.17 billion, a PE ratio of 10.22, a price-to-earnings-growth ratio of 0.74 and a beta of 0.91. The business has a fifty day simple moving average of $80.02 and a 200 day simple moving average of $90.78.
Cabot (NYSE:CBT - Get Free Report) last posted its earnings results on Monday, May 5th. The specialty chemicals company reported $1.90 earnings per share for the quarter, beating analysts' consensus estimates of $1.86 by $0.04. Cabot had a return on equity of 26.79% and a net margin of 10.60%. The business had revenue of $936.00 million during the quarter, compared to analyst estimates of $1.02 billion. During the same quarter in the previous year, the firm earned $1.78 EPS. The company's quarterly revenue was down 8.1% compared to the same quarter last year. On average, analysts anticipate that Cabot Co. will post 7.57 earnings per share for the current fiscal year.
Cabot Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 30th will be issued a $0.45 dividend. The ex-dividend date of this dividend is Friday, May 30th. This represents a $1.80 annualized dividend and a dividend yield of 2.34%. This is a boost from Cabot's previous quarterly dividend of $0.43. Cabot's dividend payout ratio is presently 23.29%.
Wall Street Analyst Weigh In
A number of research analysts have recently commented on the company. JPMorgan Chase & Co. dropped their price target on Cabot from $105.00 to $85.00 and set an "underweight" rating on the stock in a research report on Friday, February 21st. StockNews.com downgraded shares of Cabot from a "buy" rating to a "hold" rating in a report on Wednesday, May 7th. Finally, UBS Group reduced their target price on shares of Cabot from $93.00 to $83.00 and set a "neutral" rating for the company in a research note on Monday, April 7th.
Check Out Our Latest Analysis on CBT
Cabot Profile
(
Free Report)
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Featured Articles

Before you consider Cabot, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.
While Cabot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.